IRONWOOD PHARMACEUTICALS, INC. Investment Income, Interest and Dividend
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Investment Income, Interest and Dividend of $49.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-08.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2013-08-08
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for the quarter ending 2013-06-30 was $49.00K, a 11.36% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for the quarter ending 2013-03-31 was $52.00K, a 6.12% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for the quarter ending 2012-12-31 was $63.00K, a 12.50% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for the quarter ending 2012-09-30 was $41.00K, a 60.95% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for fiscal 2012 was $197.00K, a 56.80% decline from fiscal 2011.
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for fiscal 2011 was $456.00K, a 25.73% decline from fiscal 2010.
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for fiscal 2010 was $614.00K, a 155.83% increase from fiscal 2009.
- IRONWOOD PHARMACEUTICALS, INC. investment income, interest and dividend for fiscal 2009 was $240.00K.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 12 month |
|---|---|---|---|---|
| 2013-06-30 | $49.00K 10-Q · filed 2013-08-08 | $101.00K 10-Q · filed 2013-08-08 | $164.00K derived: sum of 3 quarters · filed 2013-08-08 | $205.00K derived: sum of 4 quarters · filed 2013-08-08 |
| 2013-03-31 | $52.00K 10-Q · filed 2013-04-23 | $115.00K derived: sum of 2 quarters · filed 2013-04-23 | $156.00K derived: sum of 3 quarters · filed 2013-04-23 | $200.00K derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $104.00K derived: sum of 2 quarters · filed 2013-02-21 | $148.00K derived: sum of 3 quarters · filed 2013-08-08 | $197.00K 10-K · filed 2013-02-21 |
| 2012-09-30 | $41.00K 10-Q · filed 2012-11-06 | $85.00K derived: sum of 2 quarters · filed 2013-08-08 | $134.00K 10-Q · filed 2012-11-06 | $206.00K derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-06-30 | $44.00K 10-Q · filed 2013-08-08 | $93.00K 10-Q · filed 2013-08-08 | $165.00K derived: sum of 3 quarters · filed 2013-08-08 | $270.00K derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | $49.00K 10-Q · filed 2013-04-23 | $121.00K derived: sum of 2 quarters · filed 2013-04-23 | $226.00K derived: sum of 3 quarters · filed 2013-04-23 | $351.00K derived: sum of 4 quarters · filed 2013-04-23 |
| 2011-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $177.00K derived: sum of 2 quarters · filed 2013-02-21 | $302.00K derived: sum of 3 quarters · filed 2013-02-21 | $456.00K 10-K · filed 2013-02-21 |
| 2011-09-30 | $105.00K 10-Q · filed 2012-11-06 | $230.00K derived: sum of 2 quarters · filed 2012-11-06 | $384.00K 10-Q · filed 2012-11-06 | $553.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $125.00K 10-Q · filed 2012-08-07 | $279.00K 10-Q · filed 2012-08-07 | $448.00K derived: sum of 3 quarters · filed 2013-02-21 | $636.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $154.00K 10-Q · filed 2012-05-10 | $323.00K derived: sum of 2 quarters · filed 2013-02-21 | $511.00K derived: sum of 3 quarters · filed 2013-02-21 | $700.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $357.00K derived: sum of 2 quarters · filed 2013-02-21 | $546.00K derived: sum of 3 quarters · filed 2013-02-21 | $614.00K 10-K · filed 2013-02-21 |
| 2010-09-30 | $188.00K 10-Q · filed 2011-11-09 | $377.00K derived: sum of 2 quarters · filed 2011-11-09 | $445.00K 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $189.00K 10-Q · filed 2011-08-12 | $257.00K 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $240.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |